Hypertension is a common progression factor for chronic kidney disease. Take this course to learn about the use of chlorthalidone to improve blood pressure in patients with chronic kidney disease and poorly controlled hypertension.

Upon successful completion of this application-based course, participants should be able to:
1. Recall the mechanism of action of thiazide-like diuretics
2. Describe current national guideline recommendations for management of hypertension
3. Summarize the findings of the CLICK trial
4. Discuss the strengths and limitations of the CLICK trial
5. Apply the CLICK trial results to a patient case

Angela Goodhart, PharmD, BCACP
Assistant Professor of Clinical Pharmacy and Family Medicine
West Virginia University

Dr. Goodhart has no relevant financial relationships with ineligible companies to disclose. 

To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read the article cited below and attend the live webinar.

Agarwal R, Sinha AD, Cramer AE,et al. Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease. N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730. Epub 2021 Nov 5. PMID: 34739197; PMCID: PMC9119310.

*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.

This course is included in our Pharmacist Membership. To get more courses like this sent to you every month, sign-up!

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: December 14, 2022
Planned Expiration Date: December 14, 2025

Copyright 2022, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.